Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000393420

Medchemexpress LLC Tivantinib (ARQ 197) | 905854-02-6 | 99.6% | 369.42 | 5 MG
SDP

Catalog No. 5000393420
Encompass_Preferred

Tivantinib is a highly selective c-Met tyrosine kinase inhibitor with a Ki of 355 nM. It is a low-molecular-weight compound and the first orally available selective inhibitor of c-Met. Tivantinib selectively inhibits c-Met activity in cell-free and cell-based assays, causing dose-dependent loss of proliferative capacity or caspase-dependent apoptosis in c-Met-expressing cancer cell lines.

  • Highly selective c-Met tyrosine kinase inhibitor
  • Ki of 355 nM
  • Selectively inhibits c-Met activity in cell-free and cell-based assays
  • First orally available selective inhibitor of c-Met
  • Inhibits constitutive c-Met phosphorylation in HT29 and MKN-45 cells, and HGF-induced c-Met phosphorylation in MDA-MB-231 and NCI-H441 cells with an IC50 of 100 to 300 nM
  • Strongly inhibits c-Met phosphorylation in human colon xenograft tumors (HT29)

Catalog No. 50-003-93420 Supplier Medchemexpress LLC Supplier No. 5MGHY50686
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Tivantinib is a highly selective c-Met tyrosine kinase inhibitor with a Ki of 355 nM. It is a low-molecular-weight compound and the first orally available selective inhibitor of c-Met. Tivantinib selectively inhibits c-Met activity in cell-free and cell-based assays, causing dose-dependent loss of proliferative capacity or caspase-dependent apoptosis in c-Met-expressing cancer cell lines.

  • Highly selective c-Met tyrosine kinase inhibitor
  • Ki of 355 nM
  • Selectively inhibits c-Met activity in cell-free and cell-based assays
  • First orally available selective inhibitor of c-Met
  • Inhibits constitutive c-Met phosphorylation in HT29 and MKN-45 cells, and HGF-induced c-Met phosphorylation in MDA-MB-231 and NCI-H441 cells with an IC50 of 100 to 300 nM
  • Strongly inhibits c-Met phosphorylation in human colon xenograft tumors (HT29)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.